FindMyKOL

Corey Georgesen, MD

Enriched profile

University of Nebraska Medical Center

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Omaha, NE · Midwest · United StatesSpecialtyDermatologyFocusDrug-Induced Adverse Reactions+4
Last active 2018FindMyKOL type: RegionalLatest publication2018Online presenceverified 2026PaymentsNone reportedNIH fundingNone on fileWhy? →

Corey Georgesen is a Drug-Induced Adverse Reactions physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 36 publications with 316 citations (h-index 8).

Data verified 27 Oct 2026

Overview

Updated 28 Oct 2026

Corey Georgesen, M.D., is affiliated with University of Nebraska Medical Center. The public record shows 36 publications with 316 citations (h-index 8), centered on Drug-Induced Adverse Reactions, Dermatological and COVID-19 studies, Cancer and Skin Lesions.

  • Most recent indexed publication: 2018 · Pediatric dermatology
  • Top research focus: Drug-Induced Adverse Reactions

Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atopic Dermatitis / Eczema

Research focus

OpenAlex concept fingerprint
Drug-Induced Adverse ReactionsDermatological and COVID-19 studiesCancer and Skin LesionsHealthcare Systems and TechnologyDermatology and Skin Diseases

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

316citations

Total citations across indexed works.

8h-index

Hirsch index (OpenAlex). i10-index 7.

Clinical & industry

trials, payments and federal funding
0clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    28.8%
    Azole Antifungal15.2%
    Ketoconazole100%
    Part D≥27 patients
    Tetracycline-class Drug3.6%
    Doxycycline Monohydrate100%
    Part D≥15 patients

    + 3 more classes in this area

  • Dermatology

    27%
    Corticosteroid10.9%
    Triamcinolone Acetonide100%
    Part D≥31 patients
    Interleukin-4 Receptor alpha Antagonist8.2%
    Dupixent Pen100%
    Part D<11 patients

    + 3 more classes in this area

  • Sensory organs

    23.8%
    Corticosteroid23.8%
    Clobetasol Propionate50%Hydrocortisone29%Betamethasone Dipropionate11%Dexamethasone10%
    Part D<11 patients
All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)93.2% facility · 6.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 28 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 28 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

CYNTHIA M.J. MAGRO8Shari R. Lipner5JOANNA LEE HARP5Joseph C. English4Erin X. Wei3Omar Pastor Sangüeza3Christine Ahn3Lindsay Chaney Strowd3Trevor J Lockard2Ashley S. Wysong2Louis D. Falo2Jalong Gaan2Autumn Moorhead2Sierra I. Thomas2Lindy Peta Fox2Joseph W. Mocharnuk2Divya Sharma2Sabrina A. Karim2Joseph T. McGrath2Susan K. Seo1Jonhan Ho1Alina Markova1Karim Ladak1Li‐Wei Chang1Sarah B. Lieber1Arivarasan D. Karunamurthy1Tyler D. Evans1Marissa B. Lobl1Melissa P. Pulitzer1Horatio F. Wildman1Brittany Urso1Dillon D. Clarey1Melanie Menning1Klaus Johannes BUSAM1Michael Armando Marchetti1Meenal Kheterpal1Pauline Xu1Audrey C. Woerner1Viktoryia Kazlouskaya1Andrew B. Avarbock1

Online presence

Updated 28 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/corey-georgesen-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    unmc.edu/dermatology/team/faculty/georgesen.html

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →unmc.edu ↗
  • Other

    unmc.edu/newsroom/2021/01/15/new-faculty-spotlight-corey-georgesen-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →unmc.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.